The launch of the Retatru vial marks a significant shift in the landscape to weight management . This novel medication combines dual mechanisms – stimulation of the GLP-1 receptor and reduction of the DPP-4 factor – providing a unique technique for tackling weight concerns. Early clinical data demonstrate substantial effectiveness in assisting